HealthDay on MSN4h
Some Diabetes Meds Could Lower Odds for Dementia, Parkinson's
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, also known as gliflozins, lower blood sugar by prompting the kidneys to ...
Type 2 drugs could lower dementia, Parkinson's disease risk
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...
Some diabetes medications linked to lower dementia, Parkinson's disease risk
According to a study a class of diabetes medications may be linked to a decreased risk of dementia and Parkinson disease ...
Daily6h
SGLT2 inhibitors tied to lower risk of dementia, Parkinson’s disease, suggests study
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson’s disease, according to a study ...
devdiscourse6h
Diabetes Drugs May Lower Risk of Dementia and Parkinson’s, Study Finds
Diabetes medications, specifically sodium-glucose cotransporter-2 (SGLT2) inhibitors, may be linked to a decreased risk of ...
McKnight's Long-Term Care News19h
SGLT2 inhibitors reduce dementia, Parkinson’s disease risk: study
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...
thecardiologyadvisor.com21h
GLP-1 Receptor Agonists vs SGLT2 Inhibitors and Kidney, Heart Outcomes in T2D
In patients with type 2 diabetes, GLP-1 receptor agonists and SGLT2 inhibitors have similar kidney and cardiovascular outcomes. Similar kidney and cardiovascular outcomes are found with glucagon-like ...
Some Diabetes Drugs May Protect Against Dementia and Parkinson's
Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...
Some diabetes drugs tied to lower risk of dementia, Parkinson's disease
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...